European programme in pharmacovigilance and pharmacoepidemiology (Eu2P)

European training programme in pharmacovigilance and pharmacoepidemiology coordinated from the University of Bordeaux in France, set up under the Innovative Medicines Initiative by a consortium of universities, regulators and pharmaceutical companies. Runs online and blended courses, certificates, master's and doctoral level study in drug safety, signal detection, risk management, benefit risk assessment and pharmacoepidemiological methods for people working in industry, regulatory agencies and academia across Europe and beyond.